Evidence map›Paper›PMID 35073379›Full record

ArticlePLoS pathogens2022

Herpes simplex virus-1 utilizes the host actin cytoskeleton for its release from axonal growth cones.

Kevin Danastas, Ava Larsen, Sophie Jobson, Gerry Guo, Anthony L Cunningham, Monica Miranda-Saksena

Open access · goldAbstract read
In one paragraph

Article in PLoS pathogens, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
1.7field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 12 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Kevin DanastasCentre for Virus Research, The Westmead Institute for Medical Research, The University of Sydney, Westmead, Australia.ORCID 0000-0003-2678-5646
Ava LarsenCentre for Virus Research, The Westmead Institute for Medical Research, The University of Sydney, Westmead, Australia.ORCID 0000-0003-1259-8989
Sophie JobsonCentre for Virus Research, The Westmead Institute for Medical Research, The University of Sydney, Westmead, Australia.ORCID 0000-0003-4956-4416
Gerry GuoCentre for Virus Research, The Westmead Institute for Medical Research, The University of Sydney, Westmead, Australia.ORCID 0000-0002-5824-7060
Anthony L CunninghamCentre for Virus Research, The Westmead Institute for Medical Research, The University of Sydney, Westmead, Australia.
Monica Miranda-SaksenaCentre for Virus Research, The Westmead Institute for Medical Research, The University of Sydney, Westmead, Australia.
The University of Sydney · AU

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Herpes simplex virus type 1 (HSV-1) has evolved mechanisms to exploit the host cytoskeleton during entry, replication and exit from cells. In this study, we determined the role of actin and the molecular motor proteins, myosin II and myosin V, in the transport and release of HSV-1 from axon termini, or growth cones. Using compartmentalized neuronal devices, we showed that inhibition of actin polymerization, but not actin branching, significantly reduced the release of HSV-1 from axons. Furthermore, we showed that inhibition of myosin V, but not myosin II, also significantly reduced the release of HSV-1 from axons. Using confocal and electron microscopy, we determined that viral components are transported along axons to growth cones, despite actin or myosin inhibition. Overall, our study supports the role of actin in virus release from axonal growth cones and suggests myosin V as a likely candidate involved in this process.

Indexed as

Actin CytoskeletonAnimalsAxonal TransportGrowth ConesHerpes SimplexHerpesvirus 1, HumanRatsRats, WistarVirus Release

Identifiers

PMID35073379
PMCPMC8812851
OpenAlexW4207049856

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.